Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ronaldo C Go"'
Autor:
Lorenzo Del Sorbo, Atul Malhotra, Larry Tsai, Helen Spotswood, Ronaldo C. Go, Ivan O. Rosas, Taryn Youngstein, Norbert Bräu, Andrew Ustianowski, Sanjay Bhagani, Min Bao, Sophie Dimonaco, Mariam Aziz, Nichola Cooper, Bradley D Hunter, David J. De La Zerda, Michael F. Waters, Daniel Skiest, Emily Graham, Sinisa Savic, Antonio Cubillo Gracian, Balpreet Matharu, Ivor S. Douglas
Publikováno v:
The New England journal of medicine, vol 384, iss 16
Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b63ca1c20584d448f33fd98ff7b410f
https://escholarship.org/uc/item/36k8m3wp
https://escholarship.org/uc/item/36k8m3wp
Autor:
Michael F. Waters, Lorenzo Del Sorbo, Daniel J. Skiest, Sinisa Savic, Antonio Cubillo Gracian, Bradley D. Hunter, Helen Spotswood, Andrew Ustianowski, Min Bao, Ivan O. Rosas, Larry Tsai, Mariam Aziz, Ivor S. Douglas, Nichola Cooper, Sophie Dimonaco, Norbert Bräu, Balpreet Matharu, Sanjay Bhagani, David J. De La Zerda, Ronaldo C. Go, Atul Malhotra, Emily Graham, Taryn Youngstein
BACKGROUNDCOVID-19 is associated with immune dysregulation and hyperinflammation. Tocilizumab is an anti–interleukin-6 receptor antibody.METHODSPatients hospitalized with severe COVID-19 pneumonia receiving standard care were randomized (2:1) to do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59799bab21f5339258434cebbc658983
https://doi.org/10.1101/2020.08.27.20183442
https://doi.org/10.1101/2020.08.27.20183442
Autor:
Samit Desai, Alison Morawski, Joshua Zenreich, Michele Boonstra, Rena Feinman, Sean Sadikot, Xue Geng, Samuel Singer, Laura J. Long, Ming Tan, David S. Siegel, Scott D. Rowley, Michele L. Donato, Steven I. Park, Sukhdeep Kaur, Alfred P. Gillio, Mariefel Vendivil, Elizabeth Tam, Andrea Ricourt, Melissa Baker, Abdulla Al-Khan, Marlo Kemp, Rani Sebti, Andre Goy, David S. Perlin, Martin Gutierrez, Emily Brown, Kar F. Chow, Ernest Richards, Bindu Balani, Noa Biran, Andrew Ip, Steven J. Sperber, Anna Ullrich, Stacey L. Fanning, Danit Arad, Kathryn Buttner, Cristina Cicogna, Ronaldo C. Go, Robert Korngold, Stuart L. Goldberg, Andrew L. Pecora, Tatyana Feldman, Phyllis McKiernan, Lori A. Leslie, Sarah L. Timmapuri, Hyung C. Suh, Keith M. Rose
Publikováno v:
JCI Insight
JCI Insight, Vol 6, Iss 6 (2021)
JCI Insight, Vol 6, Iss 6 (2021)
Here, we report on a phase IIa study to determine the intubation rate, survival, viral clearance, and development of endogenous Abs in patients with COVID-19 pneumonia treated with convalescent plasma (CCP) containing high levels of neutralizing anti
Autor:
Keith M. Rose, Steven Park, Michele Boonstra, Cristina Cicogna, Sukhdeep Kaur, Abdulla Al-Khan, Rani Sebti, Andrew L. Pecora, Martin Gutierrez, Alfred P. Gillio, Sarah L. Timmapuri, Hyung C. Suh, Rincourt A, Michele L. Donato, David S. Siegel, Arad D, Stuart L. Goldberg, Tam E, Alison Morawski, Sean Sadikot, Lori A. Leslie, Ernest Richards, Anna Ullrich, Andrew Ip, Joshua Zenreich, Ronaldo C. Go, Kemp M, Stacey L. Fanning, David S. Perlin, Kathryn Buttner, Ming Tan, Samit Desai, Geng X, Robert Korngold, Melissa Baker, Phyllis McKiernan, Bindu Balani, Rena Feinman, Laura J. Long, Mariefel Vendivil, Emily Brown, Samuel Singer, Scott D. Rowley, Andre Goy, Noa Biran, Steven J. Sperber, Kar Fai Chow, Ted Feldman
OBJECTIVESTo determine the rate of intubation, overall survival, viral clearance, and the development of endogenous antibodies in patients with COVID-19 pneumonia treated with convalescent plasma containing high levels of neutralizing anti-SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2cb9b73e3851ffdc1a81640a5a0227a
https://doi.org/10.1101/2020.07.20.20156398
https://doi.org/10.1101/2020.07.20.20156398